Bank of America sets Corona bond issuance in motion

By: Miguel A. Rodriguez

09:45, 14 September 2020

1589532874.jpg
Bank of America becomes the first commercial bank to fight against the virus

Yesterday, Bank of America sold $1 billion worth of corporate bonds, being the first commercial bank to specifically finance the health industry to help it fight the pandemic. 

The bank stated that all the proceedings would go to hospitals that treat patients with Covid-19, businesses that make or supply equipment necessary against the virus, and of course, to companies that produce tests or vaccines.

Although it is the first commercial bank to do so, it is not the first to start this movement. Globally, borrowers raised $102.6 billion of debt only this year to combat the impact of the virus. Chinese companies released the Pandemic Bonds, while Paraguay and Kookmin Bank sold debt in U.S. Dollars for Coronavirus relief. 

Pfizer issued a $1.25 billion bond used for funding social and environmental attempts, part of it focusing on the pandemic. USAA Capital Corp. sold an $800 million sustainability bond. 

According to HSBC, the social and sustainability bond issuance can double this year. The supply gained 69% after the African Development Bank, and the International Finance Corporation sold some of those.

Even though it gained 4.02% during yesterday’s trading session, Bank of America's stock price is 40% lower than last year. 

See the difference when trading with CAPEX.com by accessing elite features:  

  • Stellar custom service 
  • Powerful WebTrader platform and mobile app 
  • High-end integrated trading tools  
  • Full license and regulation from top regulators

Sources: marketwatch.com, cnbc.com, yahoo.com

Share this article

This information/research prepared by Miguel A. Rodriguez does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. The research analyst primarily responsible for the content of this research report, in part or in whole, certifies that the views about the companies and their securities expressed in this report accurately reflect his/her personal views and consequently any person acting on it does so entirely at their own risk.The research provided does not constitute the views of KW Investments Ltd nor is it an invitation to invest with KW Investments Ltd. The research analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report.The research analyst in not employed by KW Investments Ltd. You are encouraged to seek advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit that conforms to your specific investment objectives, financial situation, or particular financial needs before making a commitment to invest. The laws of the Republic of Seychelles shall govern any claim relating to or arising from the contents of the information/ research provided.